Zobrazeno 1 - 10
of 135
pro vyhledávání: '"E. von Hofe"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eleftheria A. Anastasopoulou, Alexandros Ardavanis, N. F. Pistamaltzian, George E. Peoples, Constantin N. Baxevanis, Diane F. Hale, Nathan M. Shumway, James L. Murray, Michael Papamichail, Sonia A. Perez, James T. Symanowski, Jennifer K. Litton, Sathibalan Ponniah, E. von Hofe, Elizabeth A. Mittendorf
Publikováno v:
Annals of Oncology. 27:1241-1248
Background AE37 is the Ii-Key hybrid of the MHC class II peptide, AE36 (HER2 aa:776–790). Phase I studies showed AE37 administered with granulocyte macrophage colony-stimulating factor (GM-CSF) to be safe and highly immunogenic. A prospective, rand
Autor:
G. Leclert, A.-M. Balazuc, L. Van Overtvelt, Hélène Moussu, Erik Wambre, Philippe Moingeon, Didier G. Ebo, C. Hoarau, M. Bonvalet, Anne Louise, G. Garcia, Bernard Maillere, E. Von Hofe, V. Bodo
Publikováno v:
Clinical & Experimental Allergy. 41:192-203
Cite this as: E. Wambre, M. Bonvalet,V. B. Bodo, B. Maille`re, G. Leclert,H. Moussu, E. Von Hofe, A. Louise,A.-M. Balazuc, D. Ebo, C. Hoarau,G. Garcia, L. Van Overtvelt and P. Moingeon, Clinical & Experimental Allergy, 2011 (41) 192–203. Summary Ba
Publikováno v:
Scandinavian Journal of Immunology. 54:39-44
The discovery of the interactions of the 'Ii-Key' segment of the Ii protein with the major histocmpatibility complex (MHC) Class II allosteric site, which is adjacent to the antigenic peptide-binding site, creates therapeutic opportunities by regulat
Autor:
M Zillman, E von Hofe, Stuart B. Levy, W Eisenberg, David G. White, A K Field, K Maneewannakul
Publikováno v:
Antimicrobial Agents and Chemotherapy. 41:2699-2704
The multiple antibiotic resistance operon (marORAB) in Escherichia coli controls intrinsic susceptibility and resistance to multiple, structurally different antibiotics and other noxious agents. A plasmid construct with marA cloned in the antisense d
Publikováno v:
Leukemia. 11:950-957
Increased expression of MDR1 is strongly implicated in the appearance of chemotherapeutic drug resistance in cancer, especially hematological malignancies. We therefore examined the potential of antisense oligonucleotides to inhibit MDR1 and restore
Autor:
Paolo Pozzilli, Nikoletta L. Kallinteris, M. Vadacca, Raffaella Buzzetti, E. von Hofe, M. G. Valorani
In order to determine whether the Ii-Key technology can enhance the presentation of specific epitopes associated with type 1 diabetes, we have designed and synthesized a series of Ii-Key/proinsulin and GAD epitope hybrid peptides. Peptides of proinsu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb4e162a9248ccbd83955860131dbf54
http://hdl.handle.net/11573/355803
http://hdl.handle.net/11573/355803
Autor:
E, Wambre, M, Bonvalet, V B, Bodo, B, Maillère, G, Leclert, H, Moussu, E, Von Hofe, A, Louise, A-M, Balazuc, D, Ebo, C, Hoarau, G, Garcia, L, Van Overtvelt, P, Moingeon
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 41(2)
A better understanding of allergen-specific CD4(+) T cell responses is needed to help improving immunological therapies. Objective To compare CD4(+) T cell responses against seasonal (Bet v 1) and perennial (Der p 1, Der p 2) allergens.Major histocom
Publikováno v:
Scandinavian journal of immunology. 54(1-2)
The discovery of the interactions of the 'Ii-Key' segment of the Ii protein with the major histocmpatibility complex (MHC) Class II allosteric site, which is adjacent to the antigenic peptide-binding site, creates therapeutic opportunities by regulat
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.